206 related articles for article (PubMed ID: 11471302)
1. [Toward individualized immunosuppression].
Grinyó JM
Nefrologia; 2001; 21(3):232. PubMed ID: 11471302
[No Abstract] [Full Text] [Related]
2. [Advances in immunossuppression in liver transplantation].
Olivera-Martínez MA
Rev Invest Clin; 2005; 57(2):237-43. PubMed ID: 16524064
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
[TBL] [Abstract][Full Text] [Related]
4. [Immunosuppressors].
Sánchez-Fructuoso AI
Nefrologia; 2008; 28 Suppl 5():21-5. PubMed ID: 18847416
[TBL] [Abstract][Full Text] [Related]
5. Evidence for immunosuppression in lung transplantation.
Hopkins PM; McNeil K
Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529
[TBL] [Abstract][Full Text] [Related]
6. [Immunosuppression for kidney transplant recipients: current strategies].
Alberú J; Urrea EM
Rev Invest Clin; 2005; 57(2):213-24. PubMed ID: 16524061
[TBL] [Abstract][Full Text] [Related]
7. The clinical application of monoclonal antibody therapies in renal transplantation.
Dhanireddy KK; Xu H; Mannon RB; Hale DA; Kirk AD
Expert Opin Emerg Drugs; 2004 May; 9(1):23-37. PubMed ID: 15155134
[TBL] [Abstract][Full Text] [Related]
8. A calcineurin antagonist-free induction immunosuppression strategy for delayed graft function in renal transplantation.
Hong JC; Kahan BD
Transplant Proc; 2001; 33(1-2):1271-2. PubMed ID: 11267288
[No Abstract] [Full Text] [Related]
9. The interleukin-2 inhibitors and their role in low-toxicity regimens.
Nashan B
Transplant Proc; 1999 Dec; 31(8A):23S-26S. PubMed ID: 10616557
[No Abstract] [Full Text] [Related]
10. Resolved: in minimizing kidney transplant immunosuppression, steroids should go before calcineurin inhibitors: con.
Pavlakis M
J Am Soc Nephrol; 2007 Dec; 18(12):3028-30. PubMed ID: 18046783
[No Abstract] [Full Text] [Related]
11. In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenic.
Ramos EL; Leggat JE; Milford EL; Kirkman RL; Tilney NL; Strom TB; Shapiro ME; Waldmann TA; Carpenter CB
Trans Assoc Am Physicians; 1989; 102():231-9. PubMed ID: 2534707
[No Abstract] [Full Text] [Related]
12. In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients.
Stock PG; Lantz M; Light S; Vincenti F
Transplant Proc; 1996 Apr; 28(2):915-6. PubMed ID: 8623460
[No Abstract] [Full Text] [Related]
13. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
Hanto DW; Chudzinski R
Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
[No Abstract] [Full Text] [Related]
14. Resolved: in minimizing kidney transplant immunosuppression, steroids should go before calcineurin inhibitors: pro.
Matas AJ
J Am Soc Nephrol; 2007 Dec; 18(12):3026-8. PubMed ID: 18003783
[TBL] [Abstract][Full Text] [Related]
15. CD4 and CD25 monoclonal antibody cocktail in kidney transplant rejection prophylaxis: clinical results of a pilot study.
Mousson C; Tanter Y; Racadot E; Wijdenes J; Chalopin JM; Chevet D; Hervé P; Rifle G
Transplant Proc; 1995 Apr; 27(2):1727-8. PubMed ID: 7725472
[No Abstract] [Full Text] [Related]
16. A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.
Kirkman RL; Shapiro ME; Carpenter CB; McKay DB; Milford EL; Ramos EL; Tilney NL; Waldmann TA; Zimmerman CE; Strom TB
Transplant Proc; 1991 Feb; 23(1 Pt 2):1066-7. PubMed ID: 1989150
[No Abstract] [Full Text] [Related]
17. [What is the best immunosuppression for the elderly kidney transplantation patient?].
Ladrière M
Nephrol Ther; 2008 Oct; 4 Suppl 3():S179-83. PubMed ID: 19000883
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin inhibitor-free immunosuppression in kidney transplantation.
Guerra G; Srinivas TR; Meier-Kriesche HU
Transpl Int; 2007 Oct; 20(10):813-27. PubMed ID: 17645419
[TBL] [Abstract][Full Text] [Related]
19. [Controversies about the use of calcineurin inhibitors in pediatric patients].
Dello Strologo L
G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
van Gelder T; Knoop CJ; Hesse CJ; Vaessen LM; Balk AH; Yzermans JN; Weimar W
Transplant Proc; 1995 Feb; 27(1):856-8. PubMed ID: 7879206
[No Abstract] [Full Text] [Related]
[Next] [New Search]
